Guardian Asset Advisors LLC Sells 406 Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI)

Guardian Asset Advisors LLC lessened its holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 9.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 4,114 shares of the medical instruments supplier’s stock after selling 406 shares during the quarter. Guardian Asset Advisors LLC’s holdings in Merit Medical Systems were worth $398,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of MMSI. Louisiana State Employees Retirement System lifted its holdings in Merit Medical Systems by 0.4% in the fourth quarter. Louisiana State Employees Retirement System now owns 28,200 shares of the medical instruments supplier’s stock valued at $2,728,000 after buying an additional 100 shares during the period. Tidal Investments LLC lifted its stake in shares of Merit Medical Systems by 1.0% in the 3rd quarter. Tidal Investments LLC now owns 10,398 shares of the medical instruments supplier’s stock valued at $1,028,000 after purchasing an additional 104 shares during the period. Glenmede Trust Co. NA boosted its position in shares of Merit Medical Systems by 0.6% in the 3rd quarter. Glenmede Trust Co. NA now owns 28,637 shares of the medical instruments supplier’s stock worth $2,830,000 after purchasing an additional 170 shares during the last quarter. Captrust Financial Advisors grew its stake in shares of Merit Medical Systems by 2.6% during the third quarter. Captrust Financial Advisors now owns 7,440 shares of the medical instruments supplier’s stock worth $735,000 after purchasing an additional 187 shares during the period. Finally, GAMMA Investing LLC increased its holdings in Merit Medical Systems by 14.7% in the fourth quarter. GAMMA Investing LLC now owns 1,494 shares of the medical instruments supplier’s stock valued at $144,000 after purchasing an additional 191 shares during the last quarter. Institutional investors and hedge funds own 99.66% of the company’s stock.

Merit Medical Systems Stock Performance

MMSI opened at $107.76 on Thursday. The company has a market capitalization of $6.28 billion, a price-to-earnings ratio of 52.82, a P/E/G ratio of 2.42 and a beta of 0.87. The business’s 50-day moving average price is $102.16 and its two-hundred day moving average price is $98.57. Merit Medical Systems, Inc. has a 1 year low of $70.70 and a 1 year high of $111.45. The company has a debt-to-equity ratio of 0.57, a current ratio of 5.36 and a quick ratio of 3.82.

Insider Buying and Selling

In other Merit Medical Systems news, Director F. Ann Millner sold 12,500 shares of the company’s stock in a transaction that occurred on Friday, November 15th. The stock was sold at an average price of $101.55, for a total transaction of $1,269,375.00. Following the completion of the transaction, the director now owns 32,391 shares of the company’s stock, valued at $3,289,306.05. This represents a 27.85 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 3.70% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. Raymond James boosted their target price on Merit Medical Systems from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 31st. Canaccord Genuity Group boosted their price objective on shares of Merit Medical Systems from $127.00 to $128.00 and gave the company a “buy” rating in a report on Wednesday, January 29th. StockNews.com lowered shares of Merit Medical Systems from a “buy” rating to a “hold” rating in a report on Sunday, November 3rd. Barrington Research boosted their price target on shares of Merit Medical Systems from $114.00 to $115.00 and gave the company an “outperform” rating in a report on Wednesday, January 29th. Finally, Needham & Company LLC upped their price objective on shares of Merit Medical Systems from $109.00 to $122.00 and gave the company a “buy” rating in a research report on Wednesday, January 29th. Two investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $109.80.

Merit Medical Systems Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.